Inhaled corticosteroids in COPD: friend or foe?
The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of
patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can …
patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can …
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
KM Kew, A Seniukovich - Cochrane Database of Systematic …, 2014 - cochranelibrary.com
Background Inhaled corticosteroids (ICS) are anti‐inflammatory drugs that have proven
benefits for people with worsening symptoms of chronic obstructive pulmonary disease …
benefits for people with worsening symptoms of chronic obstructive pulmonary disease …
Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary
CF Vogelmeier, GJ Criner, FJ Martinez… - American journal of …, 2017 - atsjournals.org
This Executive Summary of the Global Strategy for the Diagnosis, Management, and
Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 …
Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 …
[HTML][HTML] Withdrawal of inhaled glucocorticoids and exacerbations of COPD
H Magnussen, B Disse… - … England Journal of …, 2014 - Mass Medical Soc
Background Treatment with inhaled glucocorticoids in combination with long-acting
bronchodilators is recommended in patients with frequent exacerbations of severe chronic …
bronchodilators is recommended in patients with frequent exacerbations of severe chronic …
Long-term triple therapy de-escalation to indacaterol/glycopyrronium in patients with chronic obstructive pulmonary disease (SUNSET): a randomized, double-blind …
KR Chapman, JR Hurst, SM Frent, M Larbig… - American journal of …, 2018 - atsjournals.org
Rationale: There are no studies on withdrawal of inhaled corticosteroids in patients on long-
term triple therapy in the absence of frequent exacerbations. Objectives: To evaluate the …
term triple therapy in the absence of frequent exacerbations. Objectives: To evaluate the …
Tiotropium versus salmeterol for the prevention of exacerbations of COPD
C Vogelmeier, B Hederer, T Glaab… - … England Journal of …, 2011 - Mass Medical Soc
Background Treatment guidelines recommend the use of inhaled long-acting
bronchodilators to alleviate symptoms and reduce the risk of exacerbations in patients with …
bronchodilators to alleviate symptoms and reduce the risk of exacerbations in patients with …
Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline
JD Chalmers, IF Laska, FME Franssen… - European …, 2020 - Eur Respiratory Soc
Inhaled corticosteroids (ICS) combined with bronchodilators can reduce the frequency of
exacerbations in some patients with chronic obstructive pulmonary disease (COPD). There …
exacerbations in some patients with chronic obstructive pulmonary disease (COPD). There …
Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD
M Miravitlles, A Auladell-Rispau… - European …, 2021 - Eur Respiratory Soc
Inhaled corticosteroids (ICSs) are indicated for the prevention of exacerbations in COPD;
however, a significant proportion of patients at low risk of exacerbations are treated with …
however, a significant proportion of patients at low risk of exacerbations are treated with …
Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management
Chronic obstructive pulmonary disease (COPD) is a common, complex, and heterogeneous
disorder that is responsible for substantial and growing morbidity, mortality, and health-care …
disorder that is responsible for substantial and growing morbidity, mortality, and health-care …
Leitlinie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD)
C Vogelmeier, R Buhl, O Burghuber, CP Criée… - …, 2018 - thieme-connect.com
Das vorliegende Dokument ist eine Neufassung und Aktualisierung der Leitlinie zur
Diagnostik und Therapie von Patienten mit COPD, die die bisherige Version aus dem Jahr …
Diagnostik und Therapie von Patienten mit COPD, die die bisherige Version aus dem Jahr …